Literature DB >> 8927745

[Mortality of narcotic addicts using injections].

J Moskalewicz1, J Sierosławski.   

Abstract

The paper presents and discusses results of a longitudinal study on mortality of injecting drug users from detoxification unit of the Institute of Psychiatry and Neurology, Warsaw, Poland. The study was a part of an international project initiated by the World Health Organization and co-ordinated by Department of Epidemiology Lazio Region, Rome, Italy. Nine centers from six countries participated in the project. All infecting drug users attending treatment in the 1983-1992 period were enrolled. In Warsaw cohort, direct mortality rate for men was 25.7 per 1000 person-years and 14.3 per 1000 person-years for women. As compared with general population the risk of death was 11 times higher among males and 20 times higher among female drug users. Poisson's regression model showed that risk of dyeing (rate ratio) is particularly high during first year after last treatment. Almost 40% of deaths were classified as sudden deaths, cause unknown (code 798 of ICD IX) while close to one third as injuries and poisonings (800-999).

Entities:  

Mesh:

Year:  1996        PMID: 8927745

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  3 in total

1.  Nonmedical Opioid Pain Relievers and All-Cause Mortality: A 27-Year Follow-Up From the Epidemiologic Catchment Area Study.

Authors:  Linda B Cottler; Hui Hu; Bryan A Smallwood; James C Anthony; Li-Tzy Wu; William W Eaton
Journal:  Am J Public Health       Date:  2015-12-21       Impact factor: 9.308

Review 2.  Mortality among people who inject drugs: a systematic review and meta-analysis.

Authors:  Bradley M Mathers; Louisa Degenhardt; Chiara Bucello; James Lemon; Lucas Wiessing; Mathew Hickman
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

Review 3.  Examining non-AIDS mortality among people who inject drugs.

Authors:  Bradley M Mathers; Louisa Degenhardt
Journal:  AIDS       Date:  2014-11       Impact factor: 4.177

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.